NESNCHF 77.72-0.01%NOVNCHF 112.58+0.82%ROGCHF 278.40-0.23%GDAXI€25,433-0.56%FTSE£10,624-1.74%FCHI€8,125.94-2.31%STOXX50E€6,269.73-0.66%SSMICHF 13,767-2.07%AEX€1,096.53-1.75%IBEX€19,641-1.78%FTSEMIB.MI€51,811-0.70%NESNCHF 77.72-0.01%NOVNCHF 112.58+0.82%ROGCHF 278.40-0.23%GDAXI€25,433-0.56%FTSE£10,624-1.74%FCHI€8,125.94-2.31%STOXX50E€6,269.73-0.66%SSMICHF 13,767-2.07%AEX€1,096.53-1.75%IBEX€19,641-1.78%FTSEMIB.MI€51,811-0.70%
Novartis (NOVN)
SIX · CHF
CHF 112.58+0.82% (CHF 0.92)
Market open · Last known quote: Sep 10, 2026, 6:15 PM GMT+0530
Previous CloseCHF 111.66
OpenCHF 111.04
Day's RangeCHF 108.07 - CHF 111.69
52 Week RangeCHF 86.90 - CHF 135.56
Volume11.50M
Avg. Volume8.00M
Market CapCHF 217.20B
Beta (5Y Monthly)1.54
PE Ratio (TTM)N/A
EPS (TTM)N/A
Forward Dividend & YieldN/A
1y Target EstN/A
People also watch
BHP GroupBHP£3,243.00-4.65%
Rio TintoRIO.L£7,349.00-3.33%
ASML HoldingASML€1,456.80-2.72%
ASML HoldingASML.AS€1,456.80-2.72%
BPBP.L£571.38+2.56%
ShellSHEL.L£3,576.50+2.07%
LVMHMC€648.20-1.58%
HSBCHSBA.L£1,527.94-1.37%
VodafoneVOD.L£128.20+1.10%
UniCreditUCG€83.30-1.09%
VolkswagenVOW3€98.60-1.08%
SiemensSIE€261.80-0.98%
L'OréalOR€378.40-0.89%
InditexITX€54.96+0.88%
InditexITX.MC€54.96+0.88%
Related in Drug Manufacturers—General
RocheROGCHF 278.40-0.23%
NovartisNOVN.SWCHF 112.58+0.82%
RocheROG.SWCHF 278.40-0.23%
AstraZenecaAZN.L£11,592-0.50%
SanofiSAN€73.92-0.43%
Johnson & JohnsonJNJ$271.24+1.56%
Eli LillyLLY$1,135.50+1.00%
AbbVieABBV$251.11+0.08%
MerckMRK$147.19-0.23%
PfizerPFE$27.93+0.54%
AmgenAMGN$388.96-0.59%
Gilead SciencesGILD$146.53+0.61%
About Novartis
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan),…
From the companyFor more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Financial statistics
Valuation Measures
| Market Cap | CHF 217.20B |
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio | N/A |
| Price/Sales | N/A |
| Price/Book | N/A |
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 8.00M |
| Shares Outstanding | 2.00B |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Technical analysis
Summary
Sell
Last price is below the short and medium moving averages. RSI 26.4, MACD negative. Trend: downtrend.
TrendDowntrend
RSI (14)26.4
MACD-0.233
SMA 20CHF 108.76
SMA 50CHF 109.28
SMA 200CHF 109.74
SupportCHF 108.43
ResistanceCHF 109.78
Stochastic %K34.9
ATR (14)0.088
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Sell | Last close is below the 20-session average. |
| Price vs SMA 50 | Sell | Medium-term trend is down. |
| SMA cross | Sell | The 20-session average is below the 50-session average. |
| RSI (14) | Buy | RSI is oversold below 30. |
| MACD | Sell | MACD line is below zero. |
| Stochastic | Neutral | Stochastic is mid-range. |
Company profile
SectorHealthcare
IndustryDrug Manufacturers—General
Employees76,000
CEOVasant Narasimhan
HeadquartersBasel
CountrySwitzerland
Founded1 Jan 1996
Legal formAktiengesellschaft
OrganisationSwiss-American multinational pharmaceutical corporation
Website
www.novartis.com
Key management
- Vasant Narasimhan Chief Executive Officer
Historical price data
Currency in CHF| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Loading recent price history | |||||
News & official updates
TechGraph News · 2025-10-07
Global Innovation Hub: Why 7 of the World’s Top 10 Companies in Ai, Cloud, and Next-Gen Healthcare Are US-Listed
TechGraph News · 2022-12-28
Network18 Launches Phase 2 of the Netra Suraksha Initiative-India Against Diabetes
TechGraph News · 2022-12-28
ResMed Appoints Sandeep Gulati as General Manager, South Asia
TechGraph News · 2020-02-14
Coronavirus crisis: Indian generic drugmakers may face supply shortages from China if Coronavirus drags on
Price quotes and the 1D chart refresh every few seconds while this page stays open — no reload needed. Last trade is taken from the exchange feed where available; some venues delay 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.